US2023158168A1PendingUtilityA1

Process for preparing purified drug conjugates

Assignee: IMMUNOGEN INCPriority: Aug 24, 2005Filed: Sep 8, 2022Published: May 25, 2023
Est. expiryAug 24, 2025(expired)· nominal 20-yr term from priority
A61K 47/68033A61K 47/6809C07K 2317/40C07K 16/2839A61K 47/6867C07K 16/2884A61P 43/00C07K 16/2896A61P 35/00C07K 2317/24A61K 38/20A61K 47/50A61K 39/395A61K 47/6803
82
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides a process for preparing a cell-binding agent chemically coupled to a drug. The process comprises covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent and a subsequent purification step.

Claims

exact text as granted — not AI-modified
1 . A process for preparing a cell-binding agent-cytotoxic agent conjugate comprising the steps of:
 (a) contacting a cell-binding agent with a bifunctional crosslinking reagent to covalently attach a linker to the cell-binding agent and thereby prepare a first mixture comprising cell-binding agents having linkers bound thereto,   (b) subjecting the first mixture to tangential flow filtration, selective precipitation, adsorptive filtration, or adsorptive chromatography and thereby prepare a purified first mixture of cell-binding agents having linkers bound thereto,   (c) conjugating a cytotoxic agent to the cell-binding agents having linkers bound thereto in the purified first mixture by reacting the cell-binding agents having linkers bound thereto with a cytotoxic agent in a solution having a pH of about 4 to about 9 to prepare a second mixture comprising (i) cell-binding agent chemically coupled through the linker to the cytotoxic agent, (ii) free cytotoxic agent, and (iii) reaction by-products, and   (d) subjecting the second mixture to selective precipitation, adsorptive filtration, or adsorptive chromatography to purify the cell-binding agents chemically coupled through the linkers to the cytotoxic agent from the other components of the second mixture and thereby prepare a purified second mixture of cell-binding agents chemically coupled through the linkers to the cytotoxic agent, 
with the proviso that if the first mixture is subjected to tangential flow filtration in step (b), the second mixture is not subjected to adsorptive chromatography in step (d). 
     
     
         2 - 46 . (canceled)

Join the waitlist — get patent alerts

Track US2023158168A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.